A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia

NCT00394901 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuralgia, Postherpetic

Interventions

DRUG: Placebo
DRUG: Pregabalin
DRUG: Pregabalin
DRUG: Pregabalin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.